Advisory Research Inc Provention Bio, Inc. Transaction History

Advisory Research Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$6.7 - $24.21 $359,836 - $1.3 Million	-53,707 Reduced 18.6%	235,000 $5.66 Million
Q4 2022 Feb 13, 2023	BUY	$4.52 - $10.57 $242,755 - $567,682	53,707 Added 22.85%	288,707 $3.05 Million
Q4 2021 Feb 11, 2022	SELL	$5.59 - $7.39 $13,975 - $18,475	-2,500 Reduced 1.05%	235,000 $1.32 Million
Q1 2021 May 12, 2021	BUY	$10.12 - $19.45 $2.4 Million - $4.62 Million	237,500 New	237,500 $2.49 Million

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.